Bioluminescent imaging of reporter gene expression in the lungs of wildtype and model mice following the administration of PEG-stabilized DNA nanoparticles

Microscopy Research and Technique

Volumn 73, Issue 9, 2010, Pages 918-928

  Ziady, Assem G ^a,b   Kotlarchyk, Maxwell ^b   Bryant, Laura ^a   McShane, Matthew ^a   Lee, Zhenghong ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Case Western Reserve University   (United States)

Author keywords

Bioluminescent imaging; Electron microscopy; Lung gene delivery; PEG stabilized DNA nanoparticles

Indexed keywords

AMINO ACIDS; BIOLOGICAL ORGANS; BIOLUMINESCENCE; DNA; GENE EXPRESSION; GENE TRANSFER; MAMMALS;

BIOLUMINESCENT IMAGING; CYSTIC FIBROSIS; GENE DELIVERY; GENES EXPRESSION; LUNG GENE DELIVERY; PEG-STABILIZED DNA NANOPARTICLE; POLY-L-LYSINE; REPORTER-GENE EXPRESSION; TRANSGENE EXPRESSION; WILD TYPES;

NANOPARTICLES;

ANIMALIA; CYTOMEGALOVIRUS; MUS;

EID: 77956892651     PISSN: 1059910X     EISSN: 10970029     Source Type: Journal    
DOI: 10.1002/jemt.20855     Document Type: Article

References (27)

1. Brody SL, Metzger M, Danel C, Rosenfeld MA, Crystal RG. 1994. Acute responses of nonhuman primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA. Hum Gene Ther 5:821-836. (Pubitemid 24310569)
2. Borthwick DW, Shahbazian M, Krantz QT, Dorin JR, Randell SH. 2001. Evidence for stem-cell niches in the tracheal epithelium. Am J Respir Cell Mol Biol 24:662-670.
3. Buckley SM, Howe SJ, Rahim AA, Buning H, McIntosh J, Wong SP, Baker AH, Nathwani A, Thrasher AJ, Coutelle C, McKay TR, Waddington SN. 2008. Luciferin detection after intranasal vector delivery is improved by intranasal rather than intraperitoneal luciferin administration. Hum Gene Ther 19:1050-1056.
4. Cui K, Xu X, Zhao H, Wong ST. 2008. A quantitative study of factors affecting in vivo bioluminescence imaging. Luminescence 23:292-295.
5. Eckman E, Cotton CU, Kube DM, Davis PB. 1995. Dietary changes improve survival of CFTR S489X homozygous mutant mouse. Am J Physiol 269: L626-L630.
6. Fink TL, Klepcyk PJ, Oette SM, Gedeon CR, Hyatt SL, Kowalczyk TH, Moen RC, Cooper MJ. 2006. Plasmid size up to 20 kbp does not limit effective in vivo lung gene transfer using compacted DNA nanoparticles. Gene Ther 13:1048-1051.
7. Glasspool-Malone J, Steenland PR, McDonald RJ, Sanchez RA, Watts TL, Zabner J, Malone RW. 2002. DNA transfection of macaque and murine respiratory tissue is greatly enhanced by use of a nuclease inhibitor. J Gene Med 4:323-332.
8. Griesenbach U, Alton EW. 2009. Gene transfer to the lung: Lessons learned from more than 2 decades of CF gene therapy. Adv Drug Deliv Rev 61:128-139.
9. Griesenbach U, Meng C, Farley R, Cheng SH, Scheule RK, Davies MH, Wolstenholme-Hogg PC, ten Hove W, van der Hoeven P, Sinn PL, McCray PB, Jr, Inoue M, Geddes DM, Hasegawa M, Frankel G, Wiles S, Alton EW. 2008. In vivo imaging of gene transfer to the respiratory tract. Biomaterials 29:1533-1540.
10. Hildebrandt IJ, Iyer M, Wagner E, Gambhir SS. 2003. Optical imaging of transferrin targeted PEI/DNA complexes in living subjects. Gene Ther 10:758-764.
11. Konstan MW, Davis PB, Wagener JS, Hilliard KA, Stern RC, Milgram LJ, Kowalczyk TH, Hyatt SL, Fink TL, Gedeon CR, Oette SM, Payne JM, Muhammad O, Ziady AG, Moen RC, Cooper MJ. 2004. Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution. Hum Gene Ther 15:1255-1269.
12. Liu G, Li D, Pasumarthy MK, Kowalczyk TH, Gedeon CR, Hyatt SL, Payne JM, Miller TJ, Brunovskis P, Fink TL, Muhammad O, Moen RC, Hanson RW, Cooper MJ. 2003. Nanoparticles of compacted DNA transfect postmitotic cells. J Biol Chem 278:32578-32586.
13. McCaffrey A, Kay MA, Contag CH. 2003. Advancing molecular therapies through in vivo bioluminescent imaging. Mol Imaging 2:75-86.
14. Sandgren A, Albiger B, Orihuela CJ, Tuomanen E, Normark S, Henriques-Normark B. 2005. Virulence in mice of pneumococcal clonal types with known invasive disease potential in humans. J Infect Dis 192:791-800.
15. Sato A, Klaunberg B, Tolwani R. 2004. In vivo bioluminescence imaging. Comp Med 54:631-634.
16. Yang Y, Li Q, Ertl HC, Wilson JM. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 69:2004-2015.
17. Yew NS, Przybylska M, Ziegler RJ, Liu D, Cheng SH. 2001. High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter. Mol Ther 4:75-82;
18. Erratum in: Mol Ther 4 (3):280.
19. Yurek DM, Fletcher AM, Smith GM, Seroogy KB, Ziady AG, Molter J, Kowalczyk TH, Padegimas L, Cooper MJ. 2009. Long-term transgene expression in the central nervous system using DNA nanoparticles. Mol Ther 17:641-650.
20. Zabner J, Freimuth P, Puga A, Fabrega A, Welsh MJ. 1997a. Lack of high affinity fiber receptor activity explains the resistance of ciliated airway epithelia to adenovirus infection. J Clin Invest 100:1144-1149.
21. Zabner J, Cheng SH, Meeker D, Launspach J, Balfour R, Perricone MA, Morris JE, Marshall J, Fasbender A, Smith AE, Welsh MJ. 1997b. Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo. J Clin Invest 100:1529-1537.
22. Zeller W, Meier G, Burki K, Panoussis B. 1997. Adverse effects of tribromoethanol as used in the production of transgenic mice. Lab Anim 32:407-413.
23. Zhou L, Dey CR, Wert SE, DuVall MD, Frizzell RA, Whitsett JA. 1994. Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR. Science 266:1705-1708.
24. Ziady AG, Davis PB. 2002. Molecular conjugates. In: Curiel DT, Douglas JT, editors. Vector targeting for therapeutic gene delivery. Indianapolis, IN: Wiley. pp. 63-86.
25. Ziady AG, Gedeon CR, Miller T, Quan W, Payne JM, Hyatt SL, Fink T, Muhammad O, Oette S, Kowalczyk T, Moen R, Cooper MJ, Davis PB. 2003a. Transfection of airway epithelium by stable PEGylated poly-L-lysine DNA nanoparticles in vivo. Mol Ther 8:936-947.
26. Ziady AG, Gedeon CR, Muhammad O, Stillwell V, Oette S, Fink T, Quan W, Kowalczyk T, Hyatt SL, Peischl A, Seng JE, Moen RC, Cooper MJ, Davis PB. 2003b. Minimal toxicity of stabilized compacted DNA in the murine lung. Mol Ther 8:948-956.
27. Ziady AG, Kim J, Colla J, Davis PB. 2004. Defining strategies to extend duration of gene expression from targeted compacted DNA vectors. Gene Ther 11:1378-1390.